Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
JE

Jeffrey Eckert — 12 Patents

SCSchering: 4 patents #698 of 2,442Top 30%
SPSignal Pharmaceuticals: 3 patents #109 of 207Top 55%
Bristol-Myers Squibb: 3 patents #1,429 of 3,969Top 40%
LPLexicon Pharmaceuticals: 1 patents #88 of 138Top 65%
Merck: 1 patents #5,440 of 9,382Top 60%
Hazlet, NJ: #12 of 115 inventorsTop 15%
New Jersey: #7,365 of 69,400 inventorsTop 15%
Overall (All Time): #396,045 of 4,157,543Top 10%
12 Patents All Time
Jeffrey Eckert has been granted 12 US patents while listed as an inventor at Schering. The first was granted in 2005 and the most recent in April 2021. Jeffrey Eckert ranks #396,045 of 4,157,543 US inventors in our database (top 9.5%). Patent records list Jeffrey Eckert in Hazlet, NJ, US.

Issued Patents All Time

Showing 1–12 of 12 patents

Patent #TitleCo-InventorsDateApprox Value ⓘ
10968192 Crystalline solid forms of N-(1-((2-(dimethylamino)ethyl)amino)-2-methyl-1-oxopropan-2-yl)-4-(4-(2-methyl-5-((2S,3R,4R,5S,6R)-3,4,5-trihydroxy-6-(methylthio)tetrahydro-2H-pyran-2-yl)benzyl)phenyl)butanamide and methods of their synthesis Mark S. Bednarz, Kuangchu DAI, Ngiap-Kie Lim, Lauren Elizabeth SIROIS, Wenxue Wu +1 more 2021-04-06 $30,295,000
9975898 Solid forms of 1-ethyl-7-(2-methyl-6-(1H-1,2,4-triazol-3-yl)pyridin-3-YL)-3,4-dihydropyrazino [2,3-b]pyrazin-2(1H)-one as tor kinase inhibitors 2018-05-22 $110,229,000
9688623 Processes for the preparation of (S)-1-(3-ethoxy-4-methoxyphenyl)-2-methanesulfonylethylamine Jasti Venkateswaralu, Chinnapillai Rajendiran, Nallamaddi Ravikumar Reddy, Terrence Joseph Connolly, Alexander L. Ruchelman +1 more 2017-06-27 $564,989,000
9586897 Processes for the preparation of (S)-1-(3-ethoxy-4-methoxyphenyl)-2-methanesulfonylethylamine Jasti Venkateswaralu, Chinnapillai Rajendiran, Nallamaddi Ravikumar Reddy, Terrence Joseph Connolly, Alexander L. Ruchelman +1 more 2017-03-07 $148,475,000
9512129 Solid forms comprising 1-ethyl-7-(2-methyl-6-(1H-1,2,4-triazol-3-yl)pyridin-3-yl)-3,4-dihydropyrazino[2,3-b]pyrazin-2(1H)-one and a coformer 2016-12-06 $185,585,000
9416134 Solid forms of 1-ethyl-7-(2-methyl-6-(1H-1,2,4-triazol-3-yl)pyridin-3-yl)-3,4-dihydropyrazino[2,3-b]pyrazin-2(1H)-one, as TOR kinase inhibitors 2016-08-16 $584,524,000
9187417 Processes for the preparation of (S)-1-(3-ethoxy-4-methoxyphenyl)-2-methanesulfonylethylamine Jasti Venkateswaralu, Chinnapillai Rajendiran, Nallamaddi Ravikumar Reddy, Terrence Joseph Connolly, Alexander L. Ruchelman +1 more 2015-11-17 $280,363,000
8598343 Process for preparing a 2-alkynyl substituted 5-amino-pyrazolo-[4,3-e]-1,2,4-triazolo[1,5-c]pyrimidine Shen-Chun Kuo, Yonggang Chen, William W. Leong, Nanfei Zou, Gabriel Christian Kuklis 2013-12-03 $75,696,000
8198463 Process for the preparation of 6,6-dimethyl-3-azabicyclo-[3.3.0]-hexane compounds and enantiomeric salts thereof George G. Wu, Frank Xing Chen, Paitoon Rashatasakhon, George S. K. Wong, Hong-Chang Lee +6 more 2012-06-12
7723531 Process for the preparation of 6,6-dimethyl-3-azabicyclo-[3.1.0]-hexane compounds and enantiomeric salts thereof George G. Wu, Frank Xing Chen, Paitoon Rashatasakhon, George S. K. Wong, Hong-Chang Lee +6 more 2010-05-25
7049440 Enantioselective process Frank Xing Chen, Yee-Shing Wong, Feng Liang, Nanfei Zou, Agnes S. Kim-Meade +3 more 2006-05-23 $66,229,000
6875866 Process for synthesis of D1 receptor antagonists Vilas Hareshwar Dahanukar, Dinesh Gala, Brian S. Lucas, Doris P. Schumacher, Ilia Zavialov 2005-04-05 $59,021,000